HealthNotableSingle-source
5.2
GSK acquires Chimagen TCE for $750M, underscores China biotech rise
South China Morning PostLO·GB · CN·3 days ago
Researchers report discovery of VIPR, a gene-targeting system in viruses estimated to be billions of years old, potentially predating and outperforming CRISPR. The finding is preliminary and based on computational and lab studies; its practical applications remain unproven. This could reshape the gene-editing landscape if validated.